In Vivo Imaging of Gasotransmitters: Unlocking the Secrets of Nitric Oxide, Hydrogen Sulfide, and Carbon Monoxide Dynamics
Gasotransmitters represent a fascinating class of endogenous gaseous molecules that play critical roles in maintaining physiological homeostasis and mediating various pathophysiological processes. Nitric oxide (NO), hydrogen sulfide (H2S), and carbon monoxide (CO) are the quintessential gasotransmitters, exhibiting a rich palette of concentration-dependent and context-specific biological activities. Their significance extends across vasodilation, neurotransmission, immune modulation, and cellular signaling. Yet, the complexity of their roles is underscored by their paradoxical effects—acting protectively or detrimentally depending on spatial, temporal, and concentration variables within tissues. This dualistic behavior necessitates advanced methodologies for the real-time, in vivo visualization of gasotransmitter dynamics to fully elucidate their multifaceted biological functions.
Emerging imaging strategies have begun to overcome long-standing barriers inherent in the study of these gaseous molecules. The intrinsic challenges stem from their exceedingly low endogenous concentrations, often spanning picomolar to micromolar ranges, as well as rapid diffusion through tissue matrices and fleeting half-lives on the order of seconds to minutes. These factors dramatically limit the feasibility of traditional biochemical assays and ex vivo analyses to capture physiologically relevant kinetics and spatial distribution. Recent technological advances spanning fluorescence, photoacoustic imaging, chemiluminescence, afterglow, bioluminescence, magnetic resonance imaging (MRI), and radionuclide approaches have ushered in a new era of molecular visualization that offers unprecedented sensitivity, resolution, and quantitative capability.
Fluorescence-based modalities have been at the forefront of gasotransmitter imaging developments. Innovative probe chemistries employing sensitive fluorogenic substrates allow the detection of NO, H2S, and CO at physiologically meaningful concentrations. These probes hinge upon selective chemical reactions that either unquench fluorescence or induce spectral shifts, enabling dynamic tracking of gaseous species with subcellular spatial resolution. However, the intracellular and tissue microenvironment’s complexity poses selectivity challenges due to the presence of reactive oxygen and nitrogen species, other sulfur-containing compounds, and competing reductants or oxidants. The maturation of these probes continues to emphasize precise targeting, enhanced quantum yields, and minimized background fluorescence for robust in vivo applications.
Photoacoustic imaging presents an exciting complementary approach by converting absorbed light into acoustic signals, exploiting the relatively deep tissue penetration of ultrasonic waves. Gasotransmitter-sensitive contrast agents designed for photoacoustic modality enable non-invasive, real-time visualization within deep tissues, overcoming limitations of photon scattering that impair purely optical methods. For instance, tailored probes reacting selectively with NO or H2S can modulate photoacoustic signal amplitude, providing quantitative mapping of gasotransmitter distribution in whole-animal models. This capability positions photoacoustics as a critical tool for elucidating systemic gasotransmitter roles in complex organ systems and disease pathogenesis.
Chemiluminescence and afterglow imaging techniques offer additional advantages by generating luminescence without external light excitation, substantially lowering autofluorescence background noise and improving detection sensitivity. These modalities rely on chemical reactions between probes and target gasotransmitters that yield prolonged luminescent signals, facilitating time-resolved imaging over biologically relevant periods. They enable visualization of transient spikes or sustained production of gaseous molecules, thus capturing dynamic biochemical events in vivo with remarkable temporal fidelity. Efforts to develop highly selective and stable chemiluminescent probes continue to address challenges related to probe biodegradability and signal quantifiability.
Bioluminescence imaging harnesses enzymatic reactions producing light through luciferase-catalyzed processes, uniquely suited for longitudinal studies in living organisms. Genetically encoded sensors that couple luciferase activity to gasotransmitter-responsive elements are under intense investigation. These bioengineered systems promise unparalleled specificity and the ability to monitor endogenous gasotransmitter fluctuations within defined cellular populations or tissues over extended periods. While still in nascent stages, their integration with systems biology approaches holds transformative potential for decoding complex biological networks influenced by gaseous messengers.
Magnetic resonance imaging-based strategies exploit gasotransmitters’ paramagnetic or chemical exchange properties to develop contrast agents responsive to NO, H2S, or CO. MRI offers the advantage of deep tissue imaging with high spatial resolution without ionizing radiation, a critical requirement for clinical translation. Recent progress includes designing responsive probes capable of altering relaxation times or chemical shifts upon interacting with gasotransmitters, thereby enabling spatially resolved visualization and quantification. However, achieving sufficient sensitivity comparable to optical or nuclear methods remains an ongoing challenge.
Radionuclide imaging, including positron emission tomography (PET) and single-photon emission computed tomography (SPECT), introduces molecular targeting strategies employing isotopically labeled probes or radiotracers complementary to gasotransmitters’ metabolic pathways. This approach confers exquisite sensitivity and whole-body imaging potential, applicable to preclinical and eventual clinical settings. The development of radiolabeled ligands selective for downstream effectors or transient binding partners of gasotransmitters is a promising frontier for expanding disease-specific diagnostic and therapeutic monitoring capabilities.
Despite these technological breakthroughs, several formidable challenges remain in the quest to fully annotate spatiotemporal gasotransmitter landscapes in vivo. The complex redox milieu in diseased tissues poses significant hurdles for maintaining probe selectivity and stability. Achieving temporal resolution on the scale of seconds is crucial to capture rapid transient signaling events that govern physiological responses. Additionally, many existing probes exhibit limited clinical viability due to toxicity, poor pharmacokinetics, or insufficient biocompatibility, underscoring the need for translational optimization.
Integrating molecular imaging with systems biology frameworks offers the prospect of generating comprehensive, dynamic maps of gasotransmitter activities under homeostatic and pathological conditions. By combining spatially resolved molecular data with computational modeling and multi-omics analysis, researchers can better understand how localized gasotransmitter fluctuations influence broader cellular networks and organism-level phenotypes. This holistic approach will likely catalyze the discovery of novel biomarkers, therapeutic targets, and precision medicine strategies tailored to modulate gasotransmitter signaling pathways effectively.
The clinical implications of advancing in vivo gasotransmitter imaging are profound. Many diseases—including cardiovascular disorders, neurodegeneration, cancer, and inflammatory conditions—feature dysregulated production or signaling of NO, H2S, or CO. Mapping the precise kinetics and localization of these gases in patients could refine diagnostic accuracy, stratify disease stages, and monitor treatment responses in real time. Furthermore, image-guided interventions leveraging gasotransmitter modulation may emerge as personalized therapeutic paradigms, transforming patient care.
In solving these challenges, interdisciplinary collaboration spanning chemistry, bioengineering, imaging science, biology, and clinical medicine will be essential. Innovations in probe design, imaging hardware, and computational analysis are expected to further enhance the sensitivity, specificity, and practicality of gasotransmitter imaging tools. Such advances will accelerate the translation of basic research findings into clinically deployable technologies that illuminate the elusive biochemistry of gaseous signaling molecules within living organisms.
Ultimately, the dynamic spatiotemporal maps of nitric oxide, hydrogen sulfide, and carbon monoxide generated through advanced in vivo imaging have the potential to revolutionize our understanding of fundamental biological processes and complex diseases. By visualizing these ephemeral yet crucial messengers in their native environments, scientists can unravel previously inaccessible aspects of gasotransmitter biology, paving the way for groundbreaking discoveries. This convergence of molecular imaging and systems biology heralds a new era of precision medicine that leverages the power of gas signaling to enhance human health and treat disease.
As the field continues to mature, the development of clinically viable, highly selective probes with rapid response times will be paramount to achieving routine in vivo gasotransmitter imaging in humans. Harnessing the combined strengths of fluorescence, photoacoustic, chemiluminescence, bioluminescence, MRI, and radionuclide modalities provides a rich toolkit for probing diverse aspects of gasotransmitter dynamics from the molecular to the whole-organism level. These integrated imaging strategies promise unprecedented insights into the paradoxical protective and damaging roles of NO, H2S, and CO, offering a compelling window into their intoxicatingly complex interplays within health and disease.
By illuminating the invisible dance of gaseous messengers in real time, this new frontier will inspire innovative diagnostics, targeted therapies, and personalized medicine approaches grounded in the nuanced understanding of gasotransmitter biology. The future of medical imaging and bioengineering stands poised to transform with the emergence of gasotransmitter visualization as a powerful research and clinical modality, fulfilling the promise of deciphering nature’s smallest molecules with the greatest impact.
Subject of Research: In vivo imaging techniques for nitric oxide, hydrogen sulfide, and carbon monoxide gasotransmitters.
Article Title: In vivo imaging of gasotransmitters
Article References:
Lu, C., Zhang, C., Zhang, XB. et al. In vivo imaging of gasotransmitters. Nat Rev Bioeng (2026). https://doi.org/10.1038/s44222-026-00417-7
Image Credits: AI Generated
